Press Releases

NEW YORK, Dec. 9, 2019 /PRNewswire/ -- HSS, the world's leading academic medical center focused on musculoskeletal health headquartered at Hospital for Special Surgery in New York, today announced a strategic collaboration with Centro Hospitalario Serena del Mar, the medical center operated by Fundación Santa Fe de Bogot&aacut

HOUSTON, Dec. 9, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, and Chris Downs, Chief F

HANGZHOU, China, Dec. 9, 2019 /PRNewswire/ -- BJ Bioscience Inc. (the 'company') today announced that the first patient was successfully dosed on December 4, 2019 in the first-in-human (FIH) trial of the company's BJ-001 program at NEXT ONCOLOGY in San Antonio, Texas.

NORTH CHICAGO, Ill. and LA JOLLA, Calif., Dec. 9, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, today announced a collaboration to develop new therapies for a range of diseases, including i

RAMAT GAN, Israel, Dec. 9, 2019 /PRNewswire/ -- A team of medical experts from Israel's Sheba Medical Center, Tel HaShomer is embarking on an emergency deployment to the Pacific island nation of Samoa following an urgent request from the World Health Organization (WHO) for hu

SAN DIEGO, Dec. 9, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ArQule, Inc. (NASDAQ: ARQL) breached their fiduciary duties in connection with the proposed sale of the Company to Merck & Co.On December 9, 2019, ArQule announced that it had sign

Presentation Will Provide Update on Survival Trends in Various Population Subgroups Medicenna to also Present at the LD Micro Investor Conference TORONTO and HOUSTON, Dec. 9, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a

VANCOUVER, Dec. 9, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced it has received regulatory and ethics board approval of its Clinical Trial Application ("CTA"

WARRINGTON, Pa., Dec. 9, 2019 /PRNewswire/ -- Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that it has completed a $26.4 million private placement

ATLANTA, Dec. 9, 2019 /PRNewswire/ -- The American Cancer Society (ACS) announces three new members and the newly-elected leadership officers to the Board of Directors, with all terms beginning on January 1, 2020.